CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Cash from Operations (Quarterly): -27.38M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.38M |
| September 30, 2023 | -26.14M |
| June 30, 2023 | -25.44M |
| March 31, 2023 | 6.431M |
| December 31, 2022 | -18.76M |
| September 30, 2022 | -17.52M |
| June 30, 2022 | -22.44M |
| March 31, 2022 | -25.36M |
| December 31, 2021 | -14.24M |
| September 30, 2021 | -15.41M |
| June 30, 2021 | -19.21M |
| March 31, 2021 | -20.56M |
| December 31, 2020 | -14.82M |
| September 30, 2020 | -7.452M |
| June 30, 2020 | -7.749M |
| March 31, 2020 | -14.71M |
| December 31, 2019 | -28.14M |
| September 30, 2019 | -23.13M |
| June 30, 2019 | -24.25M |
| March 31, 2019 | -22.39M |
| December 31, 2018 | -19.60M |
| September 30, 2018 | -16.08M |
| Date | Value |
|---|---|
| June 30, 2018 | -12.82M |
| March 31, 2018 | -6.441M |
| December 31, 2017 | -6.072M |
| September 30, 2017 | -5.466M |
| June 30, 2017 | -5.891M |
| March 31, 2017 | -2.203M |
| December 31, 2016 | -5.402M |
| September 30, 2016 | -5.741M |
| June 30, 2016 | -6.07M |
| March 31, 2016 | -6.14M |
| December 31, 2015 | -5.196M |
| September 30, 2015 | -6.66M |
| June 30, 2015 | -5.309M |
| March 31, 2015 | -6.159M |
| December 31, 2014 | -7.472M |
| September 30, 2014 | -3.892M |
| June 30, 2014 | -4.739M |
| March 31, 2014 | -5.011M |
| December 31, 2013 | -3.537M |
| September 30, 2013 | -0.601M |
| June 30, 2013 | -2.161M |
| March 31, 2013 | -2.159M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.14M
Minimum
Dec 2019
6.431M
Maximum
Mar 2023
-18.23M
Average
-19.21M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences Inc | 2.219B |
| Assure Holdings Corp | -1.748M |
| Societal CDMO Inc (DELISTED) | 1.527M |
| AN2 Therapeutics Inc | -17.07M |
| Madrigal Pharmaceuticals Inc | -79.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -42.11M |
| Cash from Financing (Quarterly) | 2.729M |
| Free Cash Flow | -72.98M |
| Free Cash Flow Per Share (Quarterly) | -0.2318 |
| Free Cash Flow to Equity (Quarterly) | -32.64M |
| Free Cash Flow Yield | -2.12% |